Kieron Jones

ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.

Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA.

Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA.

Part of Informa Plc, The Center For Clinical Research Practice provides publications focused on regulatory requirements, and safe and ethical practices in clinical research. The company is based in Wellesley, MA. The Center For Clinical Research Practice was acquired by Medical Economics Co., part of Informa Plc from February 23, 2001 on August 16, 2000.

Pillsbury Winthrop Shaw Pittman LLP provides legal services. It offers services in education, aviation, communications, consumer and retails, corporate and securities, hospital and intellectual property. The company was founded in 1868 and is headquartered in New York, NY.

TCMI, Inc.(TCV) is a venture capital firm founded in 1995 by Jay Crandall Hoag and Richard Herrick Kimball. The firm is headquartered in Palo Alto, California.

Oncovance Technologies, Inc. provides information management and analytical services and solutions to the healthcare industry. It provides database and information management to pharmaceutical and medical device manufacturers to promote and differentiate therapeutics, IT tools that improve and personalize treatment decisions & support physician users, and platforms to drive diagnostics development and sales. The company was founded by Kevin M. Slawin, Peter T. Scardino, and Michael W. Kattan and is headquartered in Houston, TX.

Memorial Hermann Health System operates as a non-profit organization that provides healthcare services. It specializes in back pain and spine care, cancer, children's health, digestive health, emergency services, heart and vascular care, neurosurgery, neurology, stroke, orthopedics, sports medicine, rehabilitation and physical therapy, sleep medicine, transplant center, weight loss, and women?s health and maternity. Its services include alcohol and drug rehabilitation, diabetes education, home care, hospice, and medical equipment. The organization was founded 1907 and is headquartered in Houston, TX.

OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.

Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA.

3D Bio Holdings, Inc. develops term clinical applications. It focuses on whole tissue living implants. The company was founded by Hod Lipson, Larry Bonassar and Daniel L. Cohen and is headquartered in Brooklyn, NY.

AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD.

Rapha Capital Management LLC (Rapha Capital) is a venture capital firm founded in 2017 by Kevin Slawin. The firm is headquartered in Surfside, Florida.

Strata Investment Fund LLC is engaged in providing technology services. The company is headquartered in Tesuque, NM.

Fize Medical, Inc. designs and develops medical devices for real-time monitoring of vital signs. The firm offers Fize products. The company was founded by Noam Levine in 2014 and is headquartered in Modi'in, Israel.

Immunogenesis, Inc. develops immunotherapeutic for cold cancers. The company was founded by Michael A. Curran in 2019 and is headquartered in Houston, TX.

Ponce Therapeutics, Inc. is a biotechnology company based in Surfside, FL. The company is focused on developing a biotechnology platform to restore young cells in the skin by targeting p16-expressing senescent cells for elimination. This process has been shown to suppress cancer and rejuvenate tissues by restoring stem cell niches to their healthy state. Ponce Therapeutics plans to develop a wide-ranging portfolio of anti-aging products based on the best science in the nascent anti-aging field. The company was founded by Kevin M. Slawin, who has been the CEO since incorporation.

Demeetra AgBio, Inc. is an American biotechnology company that specializes in gene editing. Demeetra AgBio is located in a hub for agbiotech and is centrally located in the bluegrass state. The company has built extensive gene editing know-how and has a scientific team composed of experts with diverse backgrounds in gene editing. The company's scientific achievements include being the first to successfully edit plants and yeast with their precise cas-clover technology. Demeetra AgBio's primary focus is on engineering traits for life with advanced gene-editing technologies cas-clover & piggybac transposase. The company was founded in 2019 by Eric M. Ostertag and is currently led by CEO Jack Crawford.

DELiver Therapeutics, Inc. provides research tools and approaches that are rapidly implicating types of disease targets. The company is based in Surfside, FL. The company was founded by Kevin M. Slawin. Kevin M. Slawin has been the CEO since incorporation.